| Officer | Age | In this role | Source |
|---|---|---|---|
|
Thomas Lingelbach
Also a director
Director, President & Chief Executive Officer
|
62 |
Since 2013
13 years
|
|
|
Peter Bühler
Chief Financial Officer
|
56 |
Since 2022
4 years
|
|
|
Vincent Dequenne
Chief Operating Officer
|
58 |
Since 2022
4 years
|
|
|
Juan Carlos Jaramillo
Chief Medical Officer
|
55 |
Since 2020
6 years
|
|
|
Dipal Patel
Chief Commercial Officer
|
52 |
Since 2022
4 years
|
|
|
Petra Pesendorfer
Chief People Officer
|
40 |
Since 2024
2 years
|
|
|
Hanneke Schuitemaker
Chief Scientific Officer
|
62 |
Since 2024
2 years
|
|
|
Kendra Wergin
General Counsel and Corporate Secretary
|
40 |
Since 2024
2 years
|
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Related-party transactions come from the company’s proxy statement. Valneva SE has not filed one with the SEC.
Loading...